EurekAlert!

New meta-analysis demonstrates that access to the GeneSight test can significantly improve response and remission rates for patients with depression

SALT LAKE CITY, Sept. 3, 2025 – Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced the publication of a new meta-analysis of six ...
BMJ Open

Effectiveness of brain-computer interface interventions in autism spectrum disorder rehabilitation: a systematic review and meta-analysis protocol

Background Autism spectrum disorder (ASD) is a neurodevelopmental condition characterised by impairments in social ...
News Medical

GeneSight test improves outcomes in major depressive disorder, meta-analysis shows

Myriad Genetics, Inc., a leader in molecular diagnostic testing and precision medicine, today announced the publication of a new meta-analysis of six prospective controlled studies that included 3,532 ...
Open Heart

Sex-based differences in outcomes after transcatheter aortic valve implantation: a systematic review and meta-analysis of randomised trials

Background While female sex has historically been associated with worse outcomes following surgical aortic valve replacement, ...